<b> Eligibility criteria </b> |
Age 55 - 80 years, no statin prescription in the previous 2 years, known to be dementia free, MMSE >=26; cholesterol, BMI and SBP measurement |
Same, except MMSE which is measured within the previous 3 years |
<b> Treatment strategies </b> |
1. Initiate statin therapy at baseline and remain on it during the follow-up unless serious illnes occurs <br>
2. Refrain from taking statin therapy during the follow-up unless serious illness occurs |
Same |
<b> Randomized assignment </b> |
Random assignment to either strategy at baseline |
Random assignment at baseline within levels of sex, educational attainment, age, calendar year, smoking status, MMSE, BMI, APOE4 status, cardiovascular covariates |
<b> Start/End of follow-up </b> |
From baseline until dementia dx, death, or loss to follow-up (10 years without an MMSE measurement), or January 1st, 2015, which ever happened first |
Same |
<b> Outcome </b> |
Dementia (Death as a censoring event) <b> |
Same |
<b> Causal contrast </b> |
Intention-to-treat <br>
Per-protocol effect |
Same |